New York Cancer & Blood Specialists Welcomes Medical Oncologist-Hematologist Dr. Jacob Levenson
Bronx, NY, September 01, 2026 --(PR.com)-- New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of hematologist-oncologist, Dr. Jacob Levenson. Beginning August 31, 2026, Dr. Levenson will be practicing at NYCBS’s office located at 2330 Eastchester Road, Bronx, NY 10469.
“We are pleased to welcome Dr. Levenson to New York Cancer & Blood Specialists,” said Dr. Jeff Vacirca, CEO of NYCBS. “His clinical experience, strong research background, and focus on advancing precision therapies in oncology make him a valuable addition to our team. We look forward to the expertise he will bring to our patients and our continued efforts to advance high-quality cancer care.”
Dr. Levenson’s clinical experience spans both inpatient and outpatient oncology settings. He has managed complex solid tumors and hematologic malignancies and provides on-site oversight for chemotherapy and immunotherapy infusions, including the recognition and management of infusion reactions and urgent oncologic complications.
Dr. Levenson earned his Doctor of Medicine from the University of Central Florida College of Medicine after completing a Bachelor in Science in Biology with a minor in Economics at Brandeis University. He completed his Internal Medicine Residency at the Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, and Long Island Jewish Medical Center, where he completed his Hematology Oncology Fellowship.
“I am excited to join New York Cancer & Blood Specialists and contribute to a practice committed to advancing cancer care,” said Dr. Levenson. “I look forward to applying my clinical and research experience to help improve treatment strategies and outcomes for patients while continuing to explore advances in precision oncology.”
Dr. Levenson’s research focuses on liver-directed and precision therapies in gastrointestinal malignancies. His work includes research on hepatic artery infusion pump therapy for unresectable colorectal liver metastases, circulating tumor DNA during total neoadjuvant therapy for rectal cancer, and data analytics in pancreatic cancer. He is a co-first author of an American Society of Clinical Oncology Education Book chapter on liver-directed therapies in colorectal cancer and is a member of the American Society of Hematology and the American Society of Clinical Oncology.
To make an appointment with Dr. Levenson, please call (718) 732-4000. For more information, please visit nycancer.com.
About NYCBS
New York Cancer & Blood Specialists is a leading oncology practice dedicated to providing world-class, patient-centered, and affordable care to individuals with cancer and blood disorders throughout New York State. With locations across Long Island, New York City, and the Hudson Valley, our mission is to bring world-class cancer care close to home, where patients can heal with the support of family and community.
“We are pleased to welcome Dr. Levenson to New York Cancer & Blood Specialists,” said Dr. Jeff Vacirca, CEO of NYCBS. “His clinical experience, strong research background, and focus on advancing precision therapies in oncology make him a valuable addition to our team. We look forward to the expertise he will bring to our patients and our continued efforts to advance high-quality cancer care.”
Dr. Levenson’s clinical experience spans both inpatient and outpatient oncology settings. He has managed complex solid tumors and hematologic malignancies and provides on-site oversight for chemotherapy and immunotherapy infusions, including the recognition and management of infusion reactions and urgent oncologic complications.
Dr. Levenson earned his Doctor of Medicine from the University of Central Florida College of Medicine after completing a Bachelor in Science in Biology with a minor in Economics at Brandeis University. He completed his Internal Medicine Residency at the Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, and Long Island Jewish Medical Center, where he completed his Hematology Oncology Fellowship.
“I am excited to join New York Cancer & Blood Specialists and contribute to a practice committed to advancing cancer care,” said Dr. Levenson. “I look forward to applying my clinical and research experience to help improve treatment strategies and outcomes for patients while continuing to explore advances in precision oncology.”
Dr. Levenson’s research focuses on liver-directed and precision therapies in gastrointestinal malignancies. His work includes research on hepatic artery infusion pump therapy for unresectable colorectal liver metastases, circulating tumor DNA during total neoadjuvant therapy for rectal cancer, and data analytics in pancreatic cancer. He is a co-first author of an American Society of Clinical Oncology Education Book chapter on liver-directed therapies in colorectal cancer and is a member of the American Society of Hematology and the American Society of Clinical Oncology.
To make an appointment with Dr. Levenson, please call (718) 732-4000. For more information, please visit nycancer.com.
About NYCBS
New York Cancer & Blood Specialists is a leading oncology practice dedicated to providing world-class, patient-centered, and affordable care to individuals with cancer and blood disorders throughout New York State. With locations across Long Island, New York City, and the Hudson Valley, our mission is to bring world-class cancer care close to home, where patients can heal with the support of family and community.
Contact
New York Cancer & Blood Specialists
Mike Scanlon, Marketing Project Manager
631-574-8366
Mike Scanlon, Marketing Project Manager
631-574-8366
Contact
Categories